이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Augmenting Clinical Workflow With a Structured Chatbot for Patient History Collection and Diagnostic Support (CHAT-HX)

2026년 10월 5일 업데이트: Sonu Subudhi, Massachusetts General Hospital

Prospective Observational Evaluation of a Structured, Agentic AI Chatbot for Pre-Visit Patient History Collection and Diagnostic Support in Outpatient Clinical Workflows

Doctors spend much of each visit collecting the patient's medical history, and incomplete histories can delay diagnosis. This study tests an AI chatbot that interviews patients before their appointment and produces a structured summary of their history for the doctor. Adult patients at the first study site, a university gynecology outpatient clinic in Germany, answer the chatbot's questions on a tablet before the doctor visit. The doctor then takes the history and examines the patient as usual, without seeing the chatbot's output. Only after the doctor has finished planning care does the doctor review the chatbot's summary and rate its usefulness and accuracy. The chatbot does not change patient care. Patients also rate the ease of use and acceptability of the chatbot. The investigators will report how useful doctors find the summaries, how complete and correct the summaries are, and how patients experience the tool.

연구 개요

상세 설명

This is a prospective, observational study of an AI-based, structured history-taking tool used before a clinical visit. The tool uses large language models and follows a fixed interview plan with defined topic blocks, such as chief complaint, current history, past conditions, medications, allergies, specialty-specific history, and social and family history. It produces a structured history summary, a list of possible diagnoses, and suggested workup steps. In earlier benchmarking on more than 670 simulated and clinical cases, the system captured most clinically relevant history items and flagged clinically important warning signs.

The study is designed so that the tool does not influence care. Participants give written informed consent, then complete the AI interview on a study tablet using a pseudonymous study ID. Participants enter no name, birth date, or address. Participants then complete a short questionnaire on usability and acceptance. The treating physician takes a full history, examines the patient, and documents a plan without access to the AI output. Only afterward does the physician receive the AI output and complete a structured evaluation of its completeness, correctness, plausibility, and usefulness. No follow-up contact occurs after the visit.

The study is not randomized and has no control arm. The physician's independently obtained history serves as the reference standard. The first site is the Department of Gynecology at Leipzig University Hospital, with about 100 patients and 8 to 15 physicians. Analysis is descriptive, with subgroup comparisons by reason for visit. Additional sites may be added later. The study is a collaboration between Leipzig University Hospital and Massachusetts General Hospital and Harvard Medical School.

연구 유형

관찰

등록 (추정된)

100

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

여성

샘플링 방법

비확률 샘플

연구 인구

Adult women presenting for the first time, or with a new complaint, to the general gynecology outpatient clinic, the gynecology emergency clinic, or as referrals to the gynecology outpatient clinic at the first study site (Leipzig University Hospital, Germany). Patients are recruited consecutively in the clinic waiting area by trained study staff. Additional sites may be added later.

설명

Inclusion Criteria:

Women 18 years or older

First presentation or new complaint at the gynecology outpatient clinic (self-presentation, emergency, or referral)

Sufficient German language skills to complete a structured patient interview independently

Able to complete study participation without external support

Written informed consent

Exclusion Criteria:

Acute emergency requiring immediate treatment (for example, impaired consciousness, hemodynamic instability, or acute bleeding requiring immediate care)

Lack of legal or decisional capacity to consent

Insufficient language skills

Severe cognitive, visual, or motor impairment preventing tablet use

Previous participation in this study

Refusal or withdrawal of consent

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
개입 / 치료
Adult Clinic Patients

Adult patients with a first presentation or new complaint at the participating outpatient clinic who consent to complete the AI-based pre-visit history interview and questionnaire. Their physician completes routine care blinded to the AI output, then evaluates the AI-generated summary.

A large language model-based agentic chatbot that conducts a structured, pre-visit history interview on a study tablet and generates a history summary, differential diagnosis list, and workup suggestions. The output is released to the treating physician only after the physician has completed an independent history, examination, and care plan, and does not influence patient care.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Proportion of AI history summaries rated useful by the evaluating physician
기간: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

After completing routine care, the treating physician rates the usefulness of the AI-generated history summary on a 5-point Likert scale (1 = not useful at all, 5 = very useful). The outcome is the proportion of summaries rated 4 or higher, reported with a 95% Wilson confidence interval.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

2차 결과 측정

결과 측정
측정값 설명
기간
Completeness of the AI-generated history
기간: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Percentage of items from a standardized history grid that the AI captured correctly, reported overall and by history domain.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Correctness of the AI-generated history
기간: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Proportion of factually incorrect or missing clinically relevant items in the AI history, per physician review.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Plausibility of AI differential diagnoses
기간: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Physician rating of plausibility on a 1-5 Likert scale, and concordance of the AI differential with the physician's working diagnosis.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Plausibility of AI workup recommendations
기간: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Physician rating of the AI's suggested diagnostic workup on a 1-5 Likert scale.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Identification of clinically relevant red flags
기간: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Proportion of clinically relevant red flags correctly recognized by the AI versus not recognized, per physician review.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
Patient usability (System Usability Scale)
기간: Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)

Patient-completed System Usability Scale, score 0-100, higher scores indicating better usability.

Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
Patient acceptance and willingness to use the tool again
기간: Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)

Patient-reported acceptance, comprehensibility, empathy, comfort, trust, and willingness to use again, each on a 1-5 Likert scale.

Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
Duration of the AI interaction
기간: During the AI interview at the enrollment visit (approximately 15 minutes)

Time in minutes for the patient to complete the AI interview, recorded automatically by the system.

During the AI interview at the enrollment visit (approximately 15 minutes)
Physician-estimated time savings
기간: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

Physician's estimate, in minutes, of the time the AI history would save in clinical workflow.

Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (추정된)

2026년 10월 2일

기본 완료 (추정된)

2027년 2월 28일

연구 완료 (추정된)

2027년 10월 1일

연구 등록 날짜

최초 제출

2026년 9월 30일

QC 기준을 충족하는 최초 제출

2026년 9월 30일

처음 게시됨 (실제)

2026년 10월 6일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 7일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 10월 5일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 2026P001764
  • 201/26-ek (기타 식별자: Ethics Committee, Medical Faculty, Leipzig University)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

IPD 계획 설명

Individual participant data will not be shared with outside researchers. Participants consented under a German ethics-approved form that permits only fully anonymized, aggregated data to be shared with collaborating study partners for analysis and publication. Data are pseudonymized, are classified as health data under GDPR, and remain on servers of the clinical site. De-identified aggregate results will be reported in publications.

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다